Previous Close | 22.84 |
Open | 23.50 |
Bid | 24.20 x 100 |
Ask | 24.37 x 100 |
Day's Range | 22.77 - 25.91 |
52 Week Range | 9.26 - 26.70 |
Volume | |
Avg. Volume | 234,025 |
Market Cap | 671.683M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.13 |
Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 33.11 |
FRIENDSWOOD, Texas, May 03, 2024--Castle Biosciences will share new data supporting the utility of its DecisionDx®-SCC test at the ACMS Annual Meeting in Phoenix.
Comprehensive Analysis of Castle Biosciences' First Quarter Financial Performance
Castle Biosciences (CSTL) delivered earnings and revenue surprises of 75.68% and 6.78%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?